Anti-IL-33 Antibody (Tozorakimab)
Catalog No.
F1220
Anti-IL-33 Antibody (Tozorakimab)
Featured Products
Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody that targets interleukin-33. Tozorakimab reduces inflammation and epithelial dysfunction. Tozorakimab can be used to study chronic obstructive pulmonary disease.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
144.66 kDa
Dry ice
2376858-66-9
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
MEDI 3506, MEDI-3506
100 mM Pro 20 mM Arg pH 5.0. No preservative!
O95760
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human IL 33 His at 2 ug/mL can bind Anti-IL-33 Antibody (Tozorakimab)
IL-33
Please avoid freeze-thaw cycles.